Company: MVIS
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009765
Chunk: 216

Company: MICROVISION, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 216
---
 highly
rated (A rated securities and above) money market savings accounts and our short-term investments are comprised of highly rated corporate
and government debt securities (A rated securities and above). The values of cash and cash equivalents and investment securities, available-for-sale
as of March 31, 2025, are as follows (in thousands):

    (in thousands) 
    Amount  
    Percent 
  
    Cash and cash equivalents 
    $51,918  
     75.2%
  
    Less than one year 
     17,126  
     24.8%

    $69,044  
     100.0%

Foreign
Exchange Rate Risk

Our
major contract and collaborative research and development agreements, product sales, and licensing activity payments are currently made
in U.S. dollars or Euros. Changes in the relative value of the U.S. dollar to the Euro and other currencies may affect revenue and other
operating results as expressed in U.S. dollars. In addition, our international subsidiary financial statements are denominated in Euros.
As such, the consolidated financial statements will continue to remain subject to the impact of foreign currency translation as our international
operations continue to expand. In the future, we may enter into foreign currency hedges to offset material exposure to currency fluctuations
when we can adequately determine the timing and amounts of the exposure.

U.S. policy changes and uncertainty about such changes may increase market volatility and currency exchange rate fluctuations. Given the
relative significance of our European operations, unfavorable fluctuations in relevant exchange rates will negatively impact our financial
condition and results of operations. 

ITEM
4. CONTROLS AND PROCEDURES

Under
the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer,
we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities
Exchange Act of 1934) as of the end of the period covered by this report and, based on this evaluation, our Principal Executive Officer
and Principal Financial Officer have concluded that these disclosure controls and procedures are effective. There were no changes in
our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934) that
occurred during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect